Senior Back End Engineer, myTomorrows
Plus annual performance bonus and equity
Helping patients discover and access treatments
Job no longer available
Helping patients discover and access treatments
101-200 employees
Job no longer available
Plus annual performance bonus and equity
101-200 employees
Company mission
To enable earlier and better access to all possible treatment options.
Role
Who you are
- Strong proficiency in one or more programming languages such as Java, Python, or Ruby
- Experience with relational databases such as MySQL, PostgreSQL, or Oracle
- Experience with the cloud platforms AWS and Azure
- Experience with containerization technologies such as Docker and Kubernetes
- Excellent problem-solving skills and ability to work independently and as part of a team
- Strong communication skills and ability to work with stakeholders across the organization
- More than 5 years of experience in backend engineering or related field
- Excellent English communication skills
What the job involves
- As a Senior Backend Engineer, you will be responsible for developing and maintaining the platform infrastructure that powers our products
- You will work closely with our Frontend Engineers, DevOps Engineers, and other stakeholders to design and build scalable, reliable, and high-performance products
- Design and implement scalable and reliable backend systems and infrastructure to support our products
- Develop and maintain our micro-services to expose platform functionality to internal and external clients
- Collaborate with development and quality assurance teams to ensure high availability, scalability, and security of our systems
- Collaborate with DevOps Engineers to ensure the continuous delivery and deployment of software products
- Work with software developers to identify and implement improvements to our platform architecture and functionality
- Develop and maintain documentation of our systems and processes
- Mentor and train junior members of the backend team
- Keep up-to-date with the latest trends and technologies
Our take
In Europe alone there are around 1 million patients with debilitating diseases who have few or no treatment options for their conditions. For many, experimental drugs may hold the key to effective treatment, but an alarming 95% of such patients will not meet the eligibility criteria to enter clinical trials for these potentially life-improving medications. For patients who cannot wait for new drugs to become fully approved and available, it has historically been very difficult to access treatments in development.
This is what myTomorrows has set out to change. Founded in 2012, myTomorrows is a platform that helps patients and physicians discover and access treatments in development. It charges pharmaceutical companies for its services in assisting with clinical trials, but for patients and physicians its services are free. With a model based on encouraging reciprocity, myTomorrows is looking to disrupt this market in a holistic way - changing things for the better and benefitting all sides.
With over 5000 patients helped, 500+ physician partners onboard, and access to over 300,000 clinical research studies, myTomorrows has managed to generate some impressive early metrics. This has attracted big investor interest, and myTomorrows is planning on using new funding to invest in new technology and increase its headcount.
In terms of market trends, the 'right to try' debate is still fierce across the world, but the shift in the last 20 years has clearly been towards liberalisation, especially in the US. It looks, then, like myTomorrows' prospects are going to get even stronger in the coming years.
Kirsty
Company Specialist at Welcome to the Jungle
Insights
23% employee growth in 12 months
Company
Funding (last 2 of 4 rounds)
Jan 2017
$10.9m
SERIES A
Oct 2014
$4.9m
SEED
Total funding: $21.8m
Company benefits
- International work environment, scale-up energy, and flat organization
- Great career development opportunities in a growing company
- Learning and development budget, alongside internal knowledge-sharing sessions
- Attractive pension plan, full premium covered by us
- Hybrid work model
- Policies to support working parents
- Healthy lunch at the office
- Unlimited access to professional guidance by certified psychologists via OpenUp
- We celebrate freedom every year with an added holiday for Liberation Day on the 5th of May
Company HQ
Hoofddorppleinbuurt, Amsterdam, NH
Leadership
Ronald Brus
(Founder & CEO)A physician by trade, Ronald is also the co-founder and CBO of Leyden Labs, and spent over 14 years at biotech company Crucell.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job